June 12, 2015Open Access

Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome

Key Points

Key points are not available for this paper at this time.

Abstract

• Sarcopenia, sarcopenic obesity and visceral obesity are adverse prognostic factors in cancer patients. • CT and MRI are the current gold standard in body composition evaluation. • Body composition may affect chemotherapy tolerance and toxicities.

AI से पूछें

Bookmark

View Full Paper

Cite This Study

Yip et al. (Fri,) studied this question.

synapsesocial.com/papers/69dcc2aba5c75be4cfe53ca2 https://doi.org/https://doi.org/10.1007/s13244-015-0414-0

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Metabolic Syndrome: A Global Public Health Problem and A New Definition2005 · 879 citations
2Obesity and Cancer: The Role of Dysfunctional Adipose Tissue2009 · 712 citations
3Visceral Obesity Predicts Surgical Outcomes after Laparoscopic Colectomy for Sigmoid Colon Cancer2008 · 212 citations
4Simple proton spectroscopic imaging.1984 · 2,259 citations
5Nuclear magnetic resonance pulse sequence and discrimination of high- and low-fat tissues1984 · 84 citations

AI से पूछें

Bookmark

View Full Paper